| Literature DB >> 31364258 |
Guangze Yang1, Yun Liu1, Haofei Wang1, Russell Wilson1, Yue Hui1, Lei Yu1, David Wibowo1, Cheng Zhang1,2, Andrew K Whittaker1,2, Anton P J Middelberg1,3, Chun-Xia Zhao1.
Abstract
A large range of nanoparticles have been developed to encapsulate hydrophobic drugs. However, drug loading is usually less than 10 % or even 1 %. Now, core-shell nanoparticles are fabricated having exceptionally high drug loading up to 65 % (drug weight/the total weight of drug-loaded nanoparticles) and high encapsulation efficiencies (>99 %) based on modular biomolecule templating. Bifunctional amphiphilic peptides are designed to not only stabilize hydrophobic drug nanoparticles but also induce biosilicification at the nanodrug particle surface thus forming drug-core silica-shell nanocomposites. This platform technology is highly versatile for encapsulating various hydrophobic cargos. Furthermore, the high drug loading nanoparticles lead to better in vitro cytotoxic effects and in vivo suppression of tumor growth, highlighting the significance of using high drug-loading nanoparticles.Entities:
Keywords: biomimetic synthesis; cancer; drug delivery; nanoparticles; peptides
Year: 2019 PMID: 31364258 DOI: 10.1002/anie.201908357
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336